prof. Valerie Fonteyne
- ORCID iD
-
0000-0001-6724-1595
Show
Sort by
-
- Journal Article
- A1
- open access
Genomic determinants associated with modes of progression and patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer
-
- Journal Article
- A1
- open access
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints
-
- Journal Article
- A2
- open access
Can PET-CT improve the staging and outcome of patients with muscle-invasive bladder cancer?
-
- Journal Article
- A1
- open access
Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer
-
Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)
-
Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial
-
- Journal Article
- A1
- open access
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice
-
- Journal Article
- A1
- open access
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort
-
PI-RADS 5 in prostate magnetic resonance imaging : how important is intraprostatic invasive behavior?
-
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial